Axa S.A. Penumbra Inc Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in Penumbra Inc stock. As of the latest transaction made, Axa S.A. holds 111,119 shares of PEN stock, worth $27.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

111,119

Previous 112,260 1.02%

Holding current value

$27.5 Million

Previous $20.2 Million 6.79%

% of portfolio

0.07%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.64 - $210.12 $186,713 - $239,746	-1,141 Reduced 1.02%	111,119 $21.6 Million
Q2 2024 Aug 14, 2024	BUY	$172.27 - $223.95 $1.16 Million - $1.51 Million	6,725 Added 6.37%	112,260 $20.2 Million
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $1.78 Million - $2.21 Million	8,079 Added 8.29%	105,535 $23.6 Million
Q4 2023 Jul 16, 2024	SELL	$181.44 - $260.22 $1.47 Million - $2.1 Million	-8,079 Reduced 7.66%	97,456 $24.5 Million
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $1.42 Million - $2.04 Million	7,828 Added 8.73%	97,456 $24.5 Million
Q3 2023 Nov 14, 2023	BUY	$240.69 - $338.77 $6.38 Million - $8.99 Million	26,524 Added 42.03%	89,628 $21.7 Million
Q2 2023 Aug 14, 2023	SELL	$271.54 - $344.06 $938,985 - $1.19 Million	-3,458 Reduced 5.2%	63,104 $21.7 Million
Q1 2023 May 15, 2023	SELL	$220.43 - $278.69 $451,440 - $570,757	-2,048 Reduced 2.98%	66,562 $18.6 Million
Q4 2022 Feb 14, 2023	SELL	$151.88 - $228.5 $1.02 Million - $1.53 Million	-6,683 Reduced 8.88%	68,610 $15.2 Million
Q3 2022 Feb 14, 2023	SELL	$120.36 - $205.88 $3.16 Million - $5.41 Million	-26,273 Reduced 25.87%	75,293 $14.3 Million
Q3 2022 Nov 14, 2022	SELL	$120.36 - $205.88 $3.16 Million - $5.41 Million	-26,273 Reduced 25.87%	75,293 $14.3 Million
Q2 2022 Feb 14, 2023	BUY	$116.09 - $227.33 $3.07 Million - $6.01 Million	26,416 Added 35.15%	101,566 $12.6 Million
Q2 2022 Aug 15, 2022	BUY	$116.09 - $227.33 $3.07 Million - $6.01 Million	26,416 Added 35.15%	101,566 $12.6 Million
Q1 2022 Feb 14, 2023	SELL	$187.51 - $283.98 $26,813 - $40,609	-143 Reduced 0.19%	75,150 $16.7 Million
Q1 2022 May 13, 2022	BUY	$187.51 - $283.98 $1.52 Million - $2.3 Million	8,100 Added 12.08%	75,150 $16.7 Million
Q4 2021 Feb 14, 2022	SELL	$238.08 - $288.0 $2.46 Million - $2.97 Million	-10,320 Reduced 13.34%	67,050 $19.3 Million
Q3 2021 Nov 15, 2021	SELL	$250.72 - $291.24 $32,593 - $37,861	-130 Reduced 0.17%	77,370 $20.6 Million
Q2 2021 Aug 13, 2021	BUY	$235.0 - $310.7 $6.14 Million - $8.12 Million	26,120 Added 50.84%	77,500 $21.2 Million
Q1 2021 May 14, 2021	SELL	$175.6 - $291.43 $2.36 Million - $3.92 Million	-13,440 Reduced 20.73%	51,380 $13.9 Million
Q4 2020 Feb 12, 2021	BUY	$174.98 - $272.83 $1.66 Million - $2.58 Million	9,460 Added 17.09%	64,820 $11.3 Million
Q3 2020 Nov 13, 2020	SELL	$185.27 - $238.73 $3.68 Million - $4.74 Million	-19,860 Reduced 26.4%	55,360 $10.8 Million
Q2 2020 Aug 14, 2020	SELL	$153.32 - $191.72 $599,634 - $749,816	-3,911 Reduced 4.94%	75,220 $13.5 Million
Q1 2020 May 15, 2020	BUY	$124.34 - $193.76 $557,167 - $868,238	4,481 Added 6.0%	79,131 $12.8 Million
Q4 2019 Feb 18, 2020	BUY	$134.81 - $177.8 $18,873 - $24,892	140 Added 0.19%	74,650 $12.3 Million
Q3 2019 Nov 14, 2019	BUY	$131.82 - $183.4 $889,785 - $1.24 Million	6,750 Added 9.96%	74,510 $10 Million
Q2 2019 Aug 13, 2019	BUY	$124.65 - $167.39 $6.35 Million - $8.53 Million	50,960 Added 303.33%	67,760 $10.8 Million
Q1 2019 May 14, 2019	BUY	$115.84 - $160.31 $451,776 - $625,209	3,900 Added 30.23%	16,800 $2.47 Million
Q4 2018 Feb 13, 2019	BUY	$113.42 - $156.48 $1.09 Million - $1.5 Million	9,600 Added 290.91%	12,900 $1.58 Million
Q3 2018 Nov 08, 2018	BUY	$121.55 - $156.8 $401,115 - $517,440	3,300 New	3,300 $494,000

Others Institutions Holding PEN

# of Institutions

374

Shares Held

29.2M

Call Options Held

305K

Put Options Held

192K

View Full List

About Penumbra Inc

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.37B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

More about PEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account